Oct 5, 2026 04:03PM
Oct 5, 2026 06:09AM
Sep 23, 2026 06:05AM
Aug 10, 2026 06:53AM
Aug 3, 2026 04:46PM
Jun 11, 2026 04:07PM
Jun 8, 2026 06:57AM H.C. Wainwright Reiterates Buy Rating on ORIC Pharmaceuticals (ORIC)
May 22, 2026 07:26AM
May 15, 2026 05:10AM
May 4, 2026 04:28PM
Apr 2, 2026 06:45AM
Apr 1, 2026 01:22PM
Apr 1, 2026 06:59AM
Mar 12, 2026 11:30PM Upcoming prostate cancer data could drive shares of this pharma company
Mar 11, 2026 10:00AM
Mar 9, 2026 02:27PM
Mar 9, 2026 10:06AM
Mar 9, 2026 09:32AM
Feb 25, 2026 06:41AM
Feb 24, 2026 12:34AM
Feb 23, 2026 05:28PM ORIC Pharmaceuticals, Inc. (ORIC) Tops Q4 EPS by 7c
Jan 15, 2026 06:44AM
Jan 12, 2026 08:35AM
Jan 7, 2026 03:46AM
Dec 23, 2025 05:30PM
Dec 9, 2025 06:00PM
Dec 8, 2025 05:49AM
Dec 5, 2025 06:00AM ORIC Pharmaceuticals reports 35% response rate for lung cancer drug
Dec 4, 2025 06:50AM
Nov 20, 2025 01:00AM
Nov 17, 2025 04:14PM
Nov 13, 2025 06:36PM
Nov 6, 2025 04:00PM
Sep 26, 2025 06:42AM
Sep 4, 2025 05:42AM Guggenheim Assumes ORIC Pharmaceuticals (ORIC) at Buy
Aug 18, 2025 04:06PM
Aug 13, 2025 05:44AM
Aug 12, 2025 05:55PM
Jul 8, 2025 07:33AM
Jun 3, 2025 07:04AM
May 29, 2025 06:42AM
May 29, 2025 06:20AM Cantor Fitzgerald on ORIC Pharmaceuticals (ORIC): 'Solid Update in Prostate Cancer for ORIC-944'
May 28, 2025 04:09PM
May 21, 2025 10:08AM
May 20, 2025 10:16AM
May 20, 2025 09:59AM
May 9, 2025 07:02AM
May 5, 2025 08:48PM
Apr 28, 2025 04:30PM ORIC Pharmaceuticals Inc. (ORIC) Presents Preclinical Data to Support the Potential of ORIC-944 as a Best-in-Class PRC2 Inhibitor for the Treatment of Prostate Cancer
Mar 7, 2025 04:48PM

479,029 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All